As of April 30, 2025, TripSitter Clinic Ltd. has 6.66M shares outstanding.
| Shares Outstanding | 6.66M |
These figures are as of April 30, 2025.
| PB Ratio | -0.34 |
| P/TBV Ratio | -0.34 |
| P/FCF Ratio | -3.56 |
| P/OCF Ratio | -3.56 |
As of April 30, 2025, TripSitter Clinic Ltd. maintains a current ratio of 0.00, meaning it holds 0.0x the short-term assets needed to cover near-term liabilities.
| Debt / Equity | -47.29 |
| Debt / EBITDA | -2.56 |
These figures cover the twelve months ended April 30, 2025. Return on assets (ROA) is negative at -869.06, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -869.06 |
These figures cover the twelve months ended April 30, 2025. Free cash flow yield is negative at -28.10: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -30.19, meaning TripSitter Clinic Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -30.19 |
| FCF Yield | -28.10 |
TripSitter Clinic Ltd.'s most recent stock split took place on August 30, 2023 with a 5:1 split ratio.
| Last Split Date | 8/30/2023 |
| Split Ratio | 5:1 |
As of April 30, 2025, TripSitter Clinic Ltd. has an Altman Z-Score of -12,839.01, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -12,839.01 |
Already premium?